Effect of Aging on Haemostasis Parameters

Hopital Lariboisière100 enrolled

Overview

Aging is an independent risk factor, without any clear explanation. The primary aim of the study is to depict the effect of aging on the coagulation fibrinolysis parameters and microparticles.

Patients older than 40, without any acute disease and not receiving any antiaggregant and anticoagulant therapy will be included in the study. Blood tests will be performed for coagulation, fibrinolysis and microparticles measurement.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Aging

Eligibility

Sex: ALLMin age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * age \<40 2 groups : 1 : no history of VTE 2 : history of VTE Exclusion Criteria: * antiaggregant or anticoagulant therapy at curative dose * arterial or thrombotic event in the last month

Locations (2)

Hopital Lariboisiere

Paris, France

Hopital Lariboisière

Paris, France

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.